Literature DB >> 17900579

Dexamethasone for reduction of nausea, vomiting and analgesic use after gynecological laparoscopic surgery.

Y Fujii1, M Nakayama.   

Abstract

OBJECTIVE: To evaluate the prophylactic use of dexamethasone for reducing postoperative nausea and vomiting (PONV) and analgesic use after gynecological laparoscopic surgery.
METHODS: In a prospective randomized, double-blind, placebo-controlled trial, 90 women received either intravenous placebo, 4 mg dexamethasone or 8 mg dexamethasone at the end of surgery. PONV and analgesic requirements were evaluated.
RESULTS: The rate of patients experiencing PONV within 24 h after anesthesia was 53% in the 4 mg dexamethasone group (P=0.3) and 20% in the 8 mg dexamethasone group (P=0.001), compared with the placebo group (63%). Requests for indomethacin to relieve intolerable pain were less in patients in the 8 mg dexamethasone group compared with the 4 mg dexamethasone (P=0.047) or placebo (P=0.029) groups.
CONCLUSION: Prophylactic use of 8 mg dexamethasone is effective for reducing PONV and analgesic requirements after gynecological laparoscopic surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900579     DOI: 10.1016/j.ijgo.2007.07.017

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  3 in total

1.  Effective analgesic dose of dexamethasone after painless abortion.

Authors:  Zhe-Feng Quan; Ming Tian; Ping Chi; Xin Li; Hai-Li He
Journal:  Int J Clin Exp Med       Date:  2014-08-15

2.  Dexamethasone before total laparoscopic hysterectomy: a randomized controlled dose-response study.

Authors:  Chitra Rajeswari Thangaswamy; Vimi Rewari; Anjan Trikha; Maya Dehran
Journal:  J Anesth       Date:  2010-01-06       Impact factor: 2.078

3.  Evaluating the quality of intravenous regional anesthesia following adding dexamethasone to lidocaine.

Authors:  Ebrahim Hassani; Alireza Mahoori; Mir Mousa Aghdashi; Habibollah Pirnejad
Journal:  Saudi J Anaesth       Date:  2015 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.